Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Nyse  >  Walmart Inc.    WMT


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Walmart : Announces Dr. Cheryl Pegus as Executive Vice President of Health & Wellness

11/30/2020 | 04:16pm EST

Today, Walmart announced Dr. Cheryl Pegus as Walmart’s Executive Vice President, Health & Wellness. In this role, Dr. Pegus will further develop Walmart’s bold healthcare vision, leading health and wellness across the Walmart enterprise. Dr. Pegus will report to Walmart U.S. CEO John Furner, and her first day with Walmart will be Dec. 21st.

“I am thrilled to welcome Dr. Pegus to the Walmart family to advance our efforts to continue exploring healthcare solutions for customers and associates, and helping Americans live better – and healthier,” said John Furner, CEO of Walmart U.S. “She is an exceptional leader who will help us deliver care of the highest quality that people can receive at the right time, regardless of insurance coverage. This has never been more important as it is now, while the pandemic continues to put a strain on our healthcare system.”

Dr. Pegus joins Walmart from her most recent role as Cambia Health Solution’s President of Consumer Health Solutions and Chief Medical Officer, where she was responsible for clinical and consumer strategy to increase access to affordable, equitable care. She directed platform consumer solutions including Journi, clinical services, pharmacy, provider and medical management activities. After working in private practice for several years as a cardiologist, Dr. Pegus joined Pfizer where she focused on the development of clinical protocols and early disease management programs. She also served at Aetna, where her work supported a focus on wellness, women's health, health equity initiatives and predictive analytics. Dr. Pegus served as the first Chief Medical Officer at Walgreens.

Additionally, Dr. Pegus is co-founder of A New Beat, an organization dedicated to improving the cardiovascular health and careers of women and under-represented minorities. She sits on the board of the American Heart Association and is the immediate past board chair for the Association of Black Cardiologists.

Walmart Health & Wellness consists of more than 4,700 pharmacies, more than 3,400 Vision Centers, Walmart Health centers, digital health capabilities and Walmart Insurance Services, LLC. The company’s goal is to transform the cost and convenience of essential health care and improve the well-being of all communities we serve.

“I am humbled to be joining the Walmart organization and for the opportunity to partner internally and externally to build upon existing initiatives for accessible and affordable care for associates and the communities we serve,” said Dr. Pegus.

Walmart’s quarterly wellness days have provided more than four million free health screenings, and its $4 generic drug price program revolutionized the industry and resulted in significant savings for customers and helped lower the cost of healthcare overall, while demonstrating Walmart’s commitment to offering affordable, accessible healthcare.

About Walmart:

Walmart Inc. (NYSE: WMT) helps people around the world save money and live better - anytime and anywhere - in retail stores, online, and through their mobile devices. Each week, over 265 million customers and members visit approximately 11,500 stores under 56 banners in 27 countries and eCommerce websites. With fiscal year 2020 revenue of $524 billion, Walmart employs over 2.2 million associates worldwide. Walmart continues to be a leader in sustainability, corporate philanthropy and employment opportunity. Additional information about Walmart can be found by visiting corporate.walmart.com, on Facebook at facebook.com/walmart and on Twitter at twitter.com/walmart.

© Business Wire 2020
All news about WALMART INC.
01/25WALMART : ROSEN, A NATIONALLY RANKED LAW FIRM, Reminds Walmart Inc. Investors of..
01/25TARGET : to Pay $200 Million in Employee Bonuses, Extend COVID-19 Pandemic-Relat..
01/25WALMART : R5 Capital Downgrades Walmart to Sell from Hold, Sets $131 Price Targe..
01/25Fertitta-backed blank check firm to take Hillman public in $2.64 bln deal
01/24China Overtakes U.S. as World's Leading Destination for Foreign Direct Invest..
01/24China Overtakes U.S. as World's Leading Destination for Foreign Direct Invest..
01/24China Overtakes U.S. as World's Leading Destination for Foreign Direct Invest..
01/23WALMART : Insider Selling at WalMart (WMT) Continues with Significant Sale
01/22WALMART : Expects to Provide Up to 13 Million COVID-19 Vaccine Doses per Month
01/22WALMART : Unveils Preparation for Covid-19 Vaccine Rollouts
More news
Financials (USD)
Sales 2021 552 B - -
Net income 2021 19 385 M - -
Net Debt 2021 44 086 M - -
P/E ratio 2021 20,8x
Yield 2021 1,50%
Capitalization 414 B 414 B -
EV / Sales 2021 0,83x
EV / Sales 2022 0,82x
Nbr of Employees 2 200 000
Free-Float 48,9%
Duration : Period :
Walmart Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends WALMART INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 37
Average target price 161,50 $
Last Close Price 146,20 $
Spread / Highest target 23,1%
Spread / Average Target 10,5%
Spread / Lowest Target -28,9%
EPS Revisions
Managers and Directors
C. Douglas McMillon President, Chief Executive Officer & Director
Gregory B. Penner Non-Executive Chairman
Dacona Smith Chief Operating Officer & Senior VP-Sam's Club
Brett M. Biggs Chief Financial Officer & Executive Vice President
Clay Johnson Enterprise Chief Information Officer & EVP
Sector and Competitors
1st jan.Capitalization (M$)
WALMART INC.1.42%413 642
SEVEN & I HOLDINGS CO., LTD.9.46%34 077